Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for MandA

Tyson to pay $850m for poultry rendering business

Tyson Foods has agreed to buy the poultry rendering and blending assets of American Proteins and AMPRO Products in a deal worth around $850 million.

Tyson Foods M&A

Heska welcomes Schein joint venture with Vets First Choice

The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.

North America United States

Zoetis set to acquire diagnostics specialist Abaxis in $2bn deal

Industry leader Zoetis has signed a definitive merger agreement to acquire the second-largest veterinary diagnostics firm Abaxis. 

United States North America

Elanco adds legal expertise amidst industry talk of firm's future

Elanco has expanded its leadership team with the addition of Michael-Bryant Hicks as general counsel.

Elanco People

Diagnostics could be the next M&A move for spun-out Henry Schein

The merger between Henry Schein Animal Health and Vets First Choice could create a company thirsty for acquisitions in the diagnostics space. 

Henry Schein M&A

Rakuten enters Japanese pet insurance sector via acquisition

Japan's largest internet services company Rakuten has bought its way into the pet insurance sector – a sign of the interest in the country's companion animal sector.

M&A Companion Animals

Rumor mill spins faster three months before Elanco's future is revealed

With Elanco's date with destiny set for July 24 (the day of Eli Lilly's second-quarter results), the rumors of potential acquirers have ramped up.

M&A Elanco

Akorn reacts after Fresenius Kabi cancels acquisition

A large-scale healthcare acquisition, which features a portfolio of veterinary generics, has been terminated.

Generics M&A

Henry Schein and Vets First Choice: 'A rare moment where all stakeholders win'

Henry Schein believes the opportunity to spin-out its animal health business and merge it with Vets First Choice was too good to turn down.

Henry Schein M&A

CPF acquires 40% of Brazilian shrimp producer

Thailand's top aquaculture company Charoen Pokphand Foods (CPF) has made a small but decisive foray into the Brazilian fish farm sector. 

Aquaculture M&A

Schein to spin out of animal health business ahead of Vets Choice merger

Henry Schein is going to spin-out its animal health business and merge it with fellow US distributor Vets First Choice to create a standalone public company.

M&A Henry Schein

Building a new industry: Leveraging biotechs for animal health innovation

Being an industry with Big Pharma players at one end of the scale and smaller biotechnology firms at the other, animal health is somewhat polarized with thin interaction between these two camps. Animal Pharm analyst Sian Lazell heard one expert delve into the potential of increased collaboration to build a new industry hybrid. 

R&D Investments